Patents for A61P 27 - Drugs for disorders of the senses (53,017)
05/2002
05/30/2002CA2430100A1 Antiangiogenic agents
05/30/2002CA2429647A1 Use of thienopyrimidines
05/30/2002CA2429645A1 Use of pyrazolo[4,3-d]pyrimidines
05/30/2002CA2429630A1 Imidazole and benzimidazole caspase inhibitors and uses thereof
05/30/2002CA2429579A1 Truncated cd200
05/30/2002CA2429570A1 Pyrimidine derivatives
05/30/2002CA2429480A1 Ophthalmological preparations
05/30/2002CA2429442A1 Aminothiazoles and their use as adenosine receptor antagonists
05/30/2002CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
05/30/2002CA2428191A1 Acid derivatives useful as serine protease inhibitors
05/30/2002CA2427444A1 3-arylindole derivatives and their use as cb2 receptor agonists
05/30/2002CA2427334A1 Methods and compositions for the treatment of diseases of the eye
05/30/2002CA2427184A1 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity
05/29/2002EP1208842A2 Regulation of the immune system
05/29/2002EP1208235A1 Abc transport polynucleotides, polypeptides, and antibodies
05/29/2002EP1208214A2 Genetically engineered bleb vaccine
05/29/2002EP1208201A2 Compositions and methods for the treatment of immune related diseases
05/29/2002EP1208196A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
05/29/2002EP1208110A1 Antisense modulation of focal adhesion kinase expression
05/29/2002EP1208103A2 Reverse-turn mimetics and methods relating thereto
05/29/2002EP1208096A1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity
05/29/2002EP1208092A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor
05/29/2002EP1208085A2 Benzanilides as potassium channel openers
05/29/2002EP1207899A2 Treatment of allergic rhinitis
05/29/2002EP1207898A2 Treatment of conjunctivitis
05/29/2002EP1207863A2 New uses for potassium channel openers, such as the treatment of epilepsy
05/29/2002EP1207755A1 Methods of and compositions for inhibiting the proliferation of mammalian cells
05/29/2002DE10058663A1 Verwendung von Thienopyrimidinen Use of Thienopyrimidinen
05/29/2002DE10058662A1 Verwendung von Pyrazolo[4,3-d]pyrimidinen Use of pyrazolo [4,3-d] pyrimidines
05/29/2002CN1351614A Human antibodies that bind human IL-12 and methods for producing
05/29/2002CN1351592A Acyl derivatives which treat VL4-4 related disorders
05/29/2002CN1351503A Vaccine against streptococcus pneumoniae
05/29/2002CN1351501A Vaccine against antigens from bacteriae
05/28/2002US6395787 Prostaglandin f2a 1-ethanolamide derivatives; vision defects
05/28/2002US6395784 Obesity, hypercholesterolemia, atherosclerosis, thyroid cancer, hypothyroidism, osteoporosis, depression, arrhythmia, and congestive heart failure treatment
05/28/2002US6395764 Nosal decongestion, respiratory system disorders
05/28/2002US6395758 Small molecule carbamates or ureas for vision and memory disorders
05/28/2002US6395756 Use of ophthalmic agent
05/28/2002US6395746 Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
05/28/2002US6395309 Use of an extract of Alchemilla vulgaris to inhibit angiogenesis
05/28/2002US6395295 Otitis media, surface active phospholipid
05/28/2002CA2181377C Tetracyclic derivatives, process of preparation and use
05/28/2002CA2048300C Compositions containing a 4-quinolone derivative complexed with a divalent metal ion
05/23/2002WO2002040671A2 Immunoglobulin superfamily proteins
05/23/2002WO2002040517A2 M. tuberculosis chaperonin 60.1 and uses thereof
05/23/2002WO2002040485A1 Preventive or therapeutic medicines for diabetes containing fused-heterocycle compounds or their salts
05/23/2002WO2002040476A1 Pyridyl-substituted triazoles as tgf inhibitors
05/23/2002WO2002040468A1 Compounds
05/23/2002WO2002040450A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors
05/23/2002WO2002040448A1 Pyridone derivatives as ap2 inhibitors
05/23/2002WO2002040062A2 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative
05/23/2002WO2002040038A2 M. tuberculosis chaperonin 10 and uses thereof
05/23/2002WO2002040037A2 M. tuberculosis chaperonin 60.1 and uses thereof
05/23/2002WO2002040030A1 Combination therapy for lowering and controlling intraocular pressure
05/23/2002WO2002040028A1 Antibacterial gel eye drops
05/23/2002WO2002040025A1 Anti-inflammatory agents
05/23/2002WO2002040018A1 Treatment of glaucoma and ocular hypertension
05/23/2002WO2002040016A2 Association of calpain inhibitors and reactive oxygen species trapping agents
05/23/2002WO2002040007A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
05/23/2002WO2002039954A2 Novel compounds
05/23/2002WO2002039953A2 Texaphyrin coordination compounds and uses thereof
05/23/2002WO2001092253A3 Inhibitors of alpha l beta 2 mediated cell adhesion
05/23/2002WO2001081316A3 Substituted phenyl farnesyltransferase inhibitors
05/23/2002WO2001079444A3 Albumin fusion proteins
05/23/2002WO2001079180A3 5-substituted tetralones as inhibitors of ras farnesyl transferase
05/23/2002WO2001049316A3 Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization
05/23/2002WO2001049304A3 Aqueous ionic solutions and their uses in particular in ophthalmology
05/23/2002WO2001041760A9 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
05/23/2002WO2000063204A3 Substituted azoles
05/23/2002US20020061923 Diacid isoindoleine amide derivative
05/23/2002US20020061920 Selected fused pyrrolocarbazoles
05/23/2002US20020061918 Benzyl isooxazole and benzyl pyrazole derivatives as aldose reductase and cyclooxygenase-2 inhibitors
05/23/2002US20020061914 Benzothiazole, benzooxazole and benzoimidazole derivatives as sodium or calcium channel modulators
05/23/2002US20020061911 Enantiomers of 6-amino EM-12 and method of use
05/23/2002US20020061904 Hydroxyesters of 7-desmethylrapamycin
05/23/2002US20020061881 Compounds, compositions, and methods for stimulating neuronal growth and elongation
05/23/2002US20020061877 Substituted cyclic amine metalloprotease inhibitors
05/23/2002US20020061853 Caspase inhibtors and uses thereof
05/23/2002US20020061846 Administering to a mammal Group B- beta hemolytic streptococci(GBS) toxin receptors or immunogenic fragments to induce an immune response to the GBS receptors for prventing pathoangiogenic conditions
05/23/2002US20020061304 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor
05/23/2002US20020061281 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
05/23/2002CA2763223A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
05/23/2002CA2436854A1 Pyridone derivatives as ap2 inhibitors
05/23/2002CA2429897A1 M. tuberculosis chaperonin 10 and uses thereof
05/23/2002CA2429894A1 M. tuberculosis chaperonin 60.1 and uses thereof
05/23/2002CA2429411A1 Texaphyrin coordination compounds and uses thereof
05/23/2002CA2429195A1 Immunoglobulin superfamily proteins
05/23/2002CA2429067A1 Preventive or therapeutic medicines for diabetes containing fused-heterocycle compounds or their salts
05/23/2002CA2428997A1 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative
05/23/2002CA2428799A1 Combination therapy for lowering and controlling intraocular pressure
05/23/2002CA2428709A1 Association of calpain inhibitors and reactive oxygen species trapping agents
05/23/2002CA2428647A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
05/23/2002CA2428527A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors
05/22/2002EP1206942A1 Water channel opener compositions and medicinal compositions for ophthalmic use
05/22/2002EP1206573A1 26 human secreted proteins
05/22/2002EP1206554A1 Activatable recombinant neurotoxins
05/22/2002EP1206480A2 Methods of obtaining 2-methoxyestradiol of high purity
05/22/2002EP1206473A1 Isomeric fused pyrrolocarbazoles and isoindolones
05/22/2002EP1206471A1 Interleukin-5 inhibiting 6-azauracil derivatives
05/22/2002EP1206462A2 Heterocyclic compounds inhibiting angiogenesis